Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-04-13

FDA Approved: PRAVASTATIN SODIUM — Original Application (Biocon Pharma Inc.)

View source ↗

Summary

FDA approved Biocon Pharma's pravastatin sodium as an original ANDA, authorizing a generic version of pravastatin for lowering cholesterol. This marks the entry…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pravastatin Sodium (pravastatin sodium)

Snippet

ORIG AP for PRAVASTATIN SODIUM (PRAVASTATIN SODIUM)